7 target pathways and 154 target genes (97 up-regulated target genes and 57 down-regulated target genes) were obtained by analyzing the transcriptomic data of pDCs from MS patients without treatment and before and after the application of IFN-β treatment. The gene discussed is IFNB1; the disease is myeloid sarcoma.